Home > Insider Trading > Filing (0001209191-20-054208)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1769804	Augmedix Inc.	NONE	Blank Checks (6770)	833299164

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1826113	M. Jennifer Carter	C/O Augmedix, Inc. 1161 Mission St, Suite 210 San Francisco CA 94103		Yes	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-10-05	3,268,440	$0.00	3,268,440	No	4	A	Indirect	See footnote
Common Stock	Acquisiton	2020-10-05	666,666	$3.00	3,935,106	No	4	P	Indirect	See footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	A	Indirect	See footnote
No	4	P	Indirect	See footnote

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Warrant (right to buy)	Acquisiton	2020-10-05	303,893	$0.00	303,893	$2.88

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
303,893		2029-09-02	No	4	A	Indirect

Footnotes

On October 5, 2020, the Issuer's wholly-owned subsidiary, August Acquisition Corp. ("Acquisition Sub"), merged with and into Augmedix, Inc., a privately held Delaware corporation ("Augmedix"). Pursuant to this transaction (the "Merger"), Augmedix was the surviving corporation and became the Issuer's wholly owned subsidiary. All of the outstanding shares of stock of Augmedix held by accredited investors were converted into shares of the Issuer's common stock. All of the outstanding warrants, options and stock appreciation rights of Augmedix were assumed by the Issuer.
These securities are held of record by McKesson Ventures LLC ("McKesson"). The Reporting Person, a member of the Issuer's board of directors, isan executive vice president and chief strategy and business development officer at McKesson. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, if any.
The warrants are fully vested and exerciseable.